ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have been given an average rating of “Moderate Buy” by the sixteen research firms that are covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month […]
More Stories
NNN REIT (NYSE:NNN) Downgraded by Jefferies Financial Group to “Hold”
NNN REIT (NYSE:NNN – Get Free Report) was downgraded by Jefferies Financial Group from a “buy” rating to a “hold”...
USANA Health Sciences (NYSE:USNA) Price Target Raised to $38.00
USANA Health Sciences (NYSE:USNA – Get Free Report) had its target price increased by stock analysts at DA Davidson from...
Kopin (NASDAQ:KOPN) Coverage Initiated at Canaccord Genuity Group
Stock analysts at Canaccord Genuity Group assumed coverage on shares of Kopin (NASDAQ:KOPN – Get Free Report) in a report...
Stephens Reiterates Overweight Rating for Wingstop (NASDAQ:WING)
Wingstop (NASDAQ:WING – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts at Stephens in a research...
Critical Review: BankUnited (NYSE:BKU) versus Fifth District Savings Bank (NASDAQ:FDSB)
Fifth District Savings Bank (NASDAQ:FDSB – Get Free Report) and BankUnited (NYSE:BKU – Get Free Report) are both finance companies,...
Head to Head Comparison: SKK (NASDAQ:SKK) & MasTec (NYSE:MTZ)
MasTec (NYSE:MTZ – Get Free Report) and SKK (NASDAQ:SKK – Get Free Report) are both construction companies, but which is...